Abstract
In two population samples of men aged 30–59 years from the North of Edinburgh, a higher frequency of CHD in those with a family history of the disease in close relatives before age 60 was strongly associated with the allele status of four RFLP in the apo AI/CIII/AIV gene region. In a simultaneous multiple logistic regression analysis of CHD on a number of covariates, a family history emerged with significant odds ratio of 2.553 (p = 0.034) in subjects with minor RFLP alleles in one of the samples and with odds ratio of 3.611 (p = 0.016) in those homozygous for major alleles in the other. The apo AI/CIII/AIV related effect of family history on evidence of CHD was independent of all other variables tested, which included age, cigarette smoking, hypertension, hyperlipldaemia, socio-economic group and obesity. There was no evidence of a familial environment effect or of genotype environment interaction. The results of these studies suggest that genetic liability to CHD is influenced significantly by a locus or loci in the apo AI/CIII/AIV gene region. Since the association of this region with familial CHD involves different alleles or haplotypes in different sections of the population (different linkage phase) no single allele or haplotype identifies an individual with increased liability to CHD on account of this association. This may explain the apparently conflictng results obtained in case control studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Neufeld HN, Goldbourt U. Coronary Heart Disease: Genetic Aspects. Circulation 1983; 67: 943–54.
Goldbourt U, Neufeld HN. Genetic Aspects of Arteriosclerosis. Arteriosclerosis 1986; 6: 357–77.
Hopkins PN, Williams RR. Human Genetics and Coronary Heart Disease: A Public Health Perspective. Annu Rev Nutr 1989; 9: 303–45.
Karathanasis SK, Norum RA, Zannis VI, Breslow JL. An Inherited Polymorphism in the Human ApolipoproteinAI Gene Locus related to the Development of Atherosclerosis. Nature 1983; 301: 718–20.
Rees A, Shoulders CC, Stokes J, Galton DJ, Baralle FE. DNA Polymorphism adjacent to Human Apo-Protein A-I Gene. Relation to Hypertriglyceridaemia. Lancet 1983; i: 444–6.
Ferns GAA, Galton DJ. Haplotypes of Human Apolipoprotein AI-CIII-AIV Gene Cluster in CoronaryAtherosclerosis. Hum Genet 1986: 73: 245–9.
Breslow JL. Apolipoprotein Genetic Variation and Human Disease. Physiol Rev 1988; 68: 85–132.
Fisher EA, Coates PM and Cortner JA. Gene Polymorphisms and Variability of Human Apolipoproteins. Annu Rev Nutr 1989; 9: 139–60.
Sing FC, Moll PP. Genetics of variability of CHD risk. Int J Epidemiol 1989; 18: 5183–95
Price WH, Morris SW, Kitchin AH, Wenham PR, Burgon PRS and Donald PM. DNA restriction fragment length polymorphisms as markers of familial coronary heart disease. Lancet 1989; i: 1407–1410
Price WH, Morris SW. Kitchin AH, Wenham PR, Lowther JL, M’Kenzie PRS and Donald PM.Further evidence implicating the apo AI/CIII/ AN gene region in genetic liability to CHD. In preparation.
Kunkel LM, Smith KD, Boyer SH, et al. Analysis of Y Chromosome Specific Reiterated DNA inChromosome Variants. Proc Natl Acad Sci USA 1977; 74: 1245–49.
Lee J. Covariance adjustment of rates based on the multiple logistic regression model. J Chron Dis1981; 34: 415–426
Falconer DS. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Gen 1965; 29 51–62
Shaper AG, Pocock SJ. Walker M, Phillips AN, Whitehead TP, Macfarlane PW. Risk factors for ischaemic heart disease: the prospective phase of the British regional heart study. J Epid CommHealth 1985; 39: 197–209
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Price, W.H., Kitchin, A.H. (1991). RFLP Markers of Familial Coronary Heart Disease. In: Galton, D.J., Assmann, G. (eds) DNA Polymorphisms as Disease Markers. NATO ASI Series, vol 214. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3690-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3690-1_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6640-9
Online ISBN: 978-1-4615-3690-1
eBook Packages: Springer Book Archive